On April 4, 2025, IFPA will host the IFPA Forum 2025 for the Americas in Bogotá, Colombia. This marks the third regional forum of its kind, following successful gatherings in Europe (2022) and Asia (2023). […]
Tag: Medical Pharmaceuticals
Foro IFPA América 2025 sobre psoriasis
– Foro IFPA América 2025: “Hacia una atención más equitativa y centrada en la persona para todas las personas que viven con enfermedad psoriásica en América” El 4 de abril de 2025, la IFPA organizará […]
Turacoz Group führt die Zukunft der Evidenzsynthese mit KI-gesteuerten Living Systematic Reviews auf dem World Evidence, Pricing and Access (EPA) Congress, Europe 2025 an USA – Deutsch USA – English USA – English USA – Français Nederland – Nederlands
UTRECHT, Niederlande, 13. März 2025 /PRNewswire/ — Die Turacoz Group, ein führendes Unternehmen in den Bereichen Real-World Evidence (RWE) und Health Economics and Outcomes Research (HEOR), präsentierte auf der World EPA 2025 Conference Erkenntnisse über […]
Caliber Launches 4 Analytics and AI-driven Solutions to Revolutionize Pharma Manufacturing and Quality
PITTSBURGH, March 13, 2025 /PRNewswire/ — Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 revolution. These innovations integrate AI and […]
Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older
Brexpiprazole’s indication for the treatment of schizophrenia in adults is extended to include adolescents aged 13 years and older1 Approval follows a positive Committee for Medicinal Products for Human Use (CHMP) opinion from the European […]
